- Abstract Number: 0321
M-Phase Phosphoprotein 1 (MPP-1) Autoantibodies as a Potential Biomarker for Cranial Neuropathies in an International SLE Inception Cohort
- Abstract Number: 0510
MACE and VTE Across Upadacitinib Clinical Trial Programs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
- Abstract Number: 0261
Machine Learning and Computational Pathology Can Reveal Synovial Pathotypes in Mice and Humans
- Abstract Number: 0336
Machine Learning Approach for the Prediction of Lupus Nephritis Renal Flares Using Polygenic Risk Score and Electronic Health Record
- Abstract Number: 1607
Machine Learning Identifies Biomarker of Non-Response to Methotrexate in Rheumatoid Arthritis
- Abstract Number: 1400
Machine Learning Identifies Molecular Phenotypes That Predict Incident Cardiovascular Disease in Patients with Rheumatoid Arthritis
- Abstract Number: 1404
Machine Learning Model to Accurately Identify Rheumatoid Arthritis Patients Using Raw Electronic Health Record Data
- Abstract Number: 2233
Machine Learning Uncovers Novel mRNAs Expressed in Fibromyalgia
- Abstract Number: 0609
Macrophage Response to MAA Modified Fibrinogen in the Presence of Peptidyl Arginine Deiminase Inhibitor
- Abstract Number: 1527
Maintained Complete B Cell Depletion Is Associated with Rituximab Efficacy in Connective Tissue Disorder Interstitial Lung Disease
- Abstract Number: 0306
Maintenance of Disease Activity and Treatment Persistence in Patients with Rheumatoid Arthritis Who Switched from Combination to TNF Inhibitor Monotherapy: Results from the Rheumatology Informatics System for Effectiveness (RISE) Registry
- Abstract Number: 1646
Major Adverse Cardiovascular Events and Mortality with Opioids versus NSAIDs Initiation in Patients with Rheumatoid Arthritis
- Abstract Number: 2032
Major Salivary Gland Ultrasound and Elastography for Assessment of Disease Activity in Patients of Primary Sjögren’s Syndrome
- Abstract Number: 1984
Malignancies Risk in Rheumatoid Arthritis Patients Treated with Tofacitinib or TNF Inhibitors, a National Study: RELATION Study
- Abstract Number: 0277
Malignancy Events in the Filgotinib Rheumatoid Arthritis and Ulcerative Colitis Clinical Development Programs
- Abstract Number: 0292
Malignancy in the Upadacitinib Clinical Trial Programs for Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
- Abstract Number: 1683
Malondialdehyde-Acetaldehyde (MAA) Modified Matrix Gla Protein (MGP) Increases Citrullination by Human Macrophages
- Abstract Number: 0831
Management of Hepatic Sarcoidosis, a Retrospective Analysis of Patients at a University Hospital
- Abstract Number: 1484
Management of the Heightened Risk for Clinical Events from Atherosclerotic Cardiovascular Disease (ASCVD) in an Established Cohort of Lupus Erythematosus Patients
- Abstract Number: 0212
Managing Psoriatic Arthritis: Patients’ Views and Attitudes to Using an Online Wellness Program
- Abstract Number: 0326
Mapping Anti-Mitochondrial Antibodies over Time in a Lupus Inception Cohort
- Abstract Number: 0748
Mapping Long COVID-19 Patient Journeys for Rheumatic Disease Patients
- Abstract Number: 1160
Mapping Spondyloarthritis Susceptibility Loci in B10.RIII Mice
- Abstract Number: 0491
Markers of Neutrophil Activation in Patients with ANCA-associated Vasculitis and Large-vessel Vasculitis
- Abstract Number: 1749
Mass Spectrometry-Based HLA Peptidomics Analysis Reveals Both Expected and Novel Citrullinated Antigen Targets in Rheumatoid Arthritis
- Abstract Number: 1642
Mast Cells May Explain Sex Differences in Osteoarthritis Pain
- Abstract Number: 1942
Maybe Silent: Spine Disease in Chronic Recurrent Multifocal Osteomyelitis, Clinical Features, Risk Factors, and Red Flags
- Abstract Number: 1270
MDHAQ/RAPID3 Is a Feasible Tool to Estimate High Comorbid Fatigue and Residual Fatigue in Rheumatoid Arthritis Patients
- Abstract Number: 0054
MDSCs in Inflammatory Joints of SKG Mice Suppress T Cells and Differentiate into Osteoclasts
- Abstract Number: 1697
Measurements of Specific Activation Through the Lectin -or Classical Pathway of Complement in Patients with SLE
- Abstract Number: 2066
Measuring Sexual Dysfunction as an Indicator of Frailty in Systemic Lupus Erythematosus Population
- Abstract Number: 1094
Mechanical Loading-induced BHLHE40 Promotes Inflammatory Arthritis
- Abstract Number: 0606
Mechanism of Joint-Specific Homeobox D10 Regulation in Rheumatoid Arthritis Fibroblast-Like Synoviocytes
- Abstract Number: 0733
Median Patient Global Assessment Varies Far More According to FAST4 (fibromyalgia Assessment Screening Tool) and MDS2 (MDHAQ Depression Screen) on a Single MDHAQ (multidimensional Health Assessment Questionnaire) Than According to Primary Diagnosis
- Abstract Number: 0551
Medical Cannabis Use by Rheumatology Patients According to Inflammatory versus Non-Inflammatory Condition
- Abstract Number: 1115
Medication Co-pay Modifies Treatment Adherence in Patients with Systemic Lupus Erythematosus
- Abstract Number: 2063
Medication Cost Concerns and Disparities in Patient-reported Outcomes Among a Multiethnic Cohort of Patients with Lupus
- Abstract Number: 1947
Medication Use in Childhood Sjogren Disease
- Abstract Number: 1570
Memory CD4+T Cell Signature Is Associated with Unfavorable Prognosis in IgG4-related Disease: Risk Stratification by Machine-learning
- Abstract Number: 1377
Mental Health Screening in Juvenile Myositis: Preliminary Analysis of a Multicenter Pilot Study
- Abstract Number: 2078
Mesangial Lupus Nephritis: Long Term Outcomes
- Abstract Number: 1007
Metabolic Disorders and Abnormal Dietary Patterns and Their Association with Psoriatic Arthritis Activity: The Dietary Intervention in PsA (DIPSA) Study
- Abstract Number: 0320
Metabolomics in Systemic Lupus Erythematosus and Pregnancy – A Prospective Observational Longitudinal Study
- Abstract Number: 2242
Metabolomics-based Identification of Metabolic Dysfunction in Inclusion Body Myositis
- Abstract Number: 2040
Metformin Improves Objective Measures of Dry Eyes and Focus Score in Sjögren′s Disease: A Retrospective Observational Study
- Abstract Number: 0747
Methotrexate and Hydroxychloroquine Used as Single Agent May Diminish Breakthrough Infection After COVID-19 Vaccination
- Abstract Number: 0926
Methotrexate Polyglutamates Exposure – Response Modelling in a Large Cohort of Rheumatoid Arthritis Patients Starting Methotrexate
- Abstract Number: 0915
Methotrexate Therapy Results in Disparate Methotrexate Polyglutamate Profiles in Peripheral Blood Mononuclear Cells Compared with Erythrocytes
- Abstract Number: 1137
MHC Class I Polypeptide-Related Sequence a Variant Predicts Real-World Response to Anti-TNF Therapy
- Abstract Number: 1991
Mice Do Not Develop CIA: Knocking out of Kv1.3 Renders CD4+TEMCells Resistant to Activation
- Abstract Number: 0028
Microenvironmental Stiffness Modulates Macrophage Responsiveness and Communication with Mesenchymal Stem Cells
- Abstract Number: 1557
Microvascular Involvement in Behçet’s Disease: Study of Nailfold Capillaroscopy in Patients from a National Referral Center
- Abstract Number: 0170
Minimal Clinically Important Difference in Myositis Response Criteria
- Abstract Number: 2131
Minimal Disease Activity Response Patterns in Bio-Naïve Patients Treated with Guselkumab: A Machine Learning Analysis
- Abstract Number: 1017
Minimal Important Difference (MID), Minimal Detectable Change (MDC), and Disease Activity Thresholds for Two Novel Composite Instruments (3VAS, 4VAS) in Patients with Psoriatic Arthritis: Pooled Analysis of Three Phase 3 Studies
- Abstract Number: 0252
Mitochondrial Content in Skeletal Muscle of Individuals with Rheumatoid Arthritis Is Associated with Physical Activity Level
- Abstract Number: 0041
Modeling Juvenile Dermatomyositis with Engineered Human Skeletal Muscle: Effects of Type I Interferonβ and Janus Kinase Inhibitors
- Abstract Number: 1510
Modifying Lifestyle Factors May Offer the Potential to Enhance the Outcome of Tumour Necrosis Factor Inhibitors in Axial Spondyloarthritis – Data from 14 European Countries
- Abstract Number: 1560
Modulation of NKG2D Expression on NK, NKT and CD8+ T Lymphocytes by in Vitro Treatments of Immune Cells from Patients with Behçet Disease
- Abstract Number: 0975
Modulation of T, B, and Innate Cell-Associated Pharmacodynamic Biomarkers in a Phase 3 Trial of Anifrolumab in Moderate to Severe SLE
- Abstract Number: 0646
Modulation of Type I IFN Production and Regulatory T Cells by the PKGI/ROCK Signaling Pathway
- Abstract Number: 1680
Module Signatures of Synovial Single-cell States Identify Disease Phenotypes in Early Treatment-naive Rheumatoid Arthritis
- Abstract Number: 1428
Molecular and Clinical Profiling of Rheumatoid Arthritis Patients Predicts the Response to Rituximab
- Abstract Number: 0558
Molecular Interplay Between Mammalian Target of Rapamycin (mTOR) and the YAP Pathway Mediates Rheumatoid Arthritis Synovial Fibroblast Activation
- Abstract Number: 1139
Molecular Pathways Identified from Risk Alleles Identify Mechanistic Differences in Systemic Lupus Erythematosus Patients of East Asian and European Ancestry
- Abstract Number: 0590
Molecular Profiling of Normal Human Synovium Reveals Striking Impact of Adipocytes and Homeostatic Cortisol Signaling
- Abstract Number: 0233
Monoarthritis Virtual Teaching Module for Rheumatology Learners
- Abstract Number: 0248
Monocyte Chemoattractant Protein-1, Vascular Cell Adhesion Protein-1 and Asymmetric Dimethylarginine as Potential Biomarkers of Interstitial Lung Disease Associated with RA
- Abstract Number: 1118
Monocyte Transcriptomic Analysis Uncovers Heterogeneous Gene Expression Profiles in Systemic Lupus Erythematous (SLE) with and Without Subclinical Atherosclerosis
- Abstract Number: 1950
Morbidities Associated with Serious Infections in Patients with Rheumatoid Arthritis
- Abstract Number: 2011
More Meticulously Following Treat-to-target in RA Does Not Lead to Less Radiographic Progression: A Longitudinal Analysis in BIODAM
- Abstract Number: 1775
More Than Half of Patients with Osteoarthritis Have Positive Screening for Fibromyalgia And/or Depression, Feasibly Assessed in Routine Care on Indices Within a Single MDHAQ (multidimensional Health Assessment Questionnaire)
- Abstract Number: 1778
More Than Half of RA Patients with a Lifetime History of Mood Disorders or Anxious and Depressed During COVID-19 Pandemic
- Abstract Number: 1953
Mortality in Rheumatoid Arthritis: Changing Causes and Predictive Factors. Study of a Cohort Followed Prospectively
- Abstract Number: 1845
Mortality Prognostic Factors of Critically Ill Patients with Systemic Autoimmune Diseases Admitted in a Medical Intensive Care Unit: A 20-year Cohort Study
- Abstract Number: 0381
Most Disease Outcome Measures but Not ASDAS Are Influenced by Gender in Patients with Axial SpA: Results from ASAS-PerSpA
- Abstract Number: 1541
MRI Digital Artery Volume Index (DAVIX) Predicts Future Digital Ulcers and Disease Progression in Systemic Sclerosis
- Abstract Number: 0493
MRI Is Superior to Ultrasound of Supraaortic Arteries in Detecting Giant Cell Arteritis – Experience of a Single Center
- Abstract Number: 2257
MRI Spinal Lesions in Patients Without MRI or Radiographic Lesions in the Sacroiliac Joints Typical of Axial Spondyloarthritis
- Abstract Number: 2182
mRNA Vaccine Against Fibroblast Activation Protein Ameliorates Murine Models of Inflammatory Arthritis
- Abstract Number: 0004
mTORC1 Drives the Spectrum of Pathology in Systemic JIA and Macrophage Activation Syndrome
- Abstract Number: 2183
mTORC2 Contributes to Murine Systemic Autoimmunity
- Abstract Number: 1221
Multi-Center Validation of Cell-Bound Complement Activation Products and a Multianalyte Assay Panel Distinguishing Systemic Lupus Erythematosus from Primary Fibromyalgia
- Abstract Number: 1922
Multi-Joint Osteoarthritis Phenotypes by Race/Ethnicity and Sex: Preliminary Descriptive Data from the Johnston County Health Study
- Abstract Number: 2213
Multi-omic Analysis of Macrophage Activation Syndrome Associated with sJIA Reveals a Potential Role of Type I Interferons in the Expansion of Cycling T Cells
- Abstract Number: 0342
Multi-Parametric Interrogation of the Systemic Lupus Erythematosus (SLE) Immunome Reveals Multiple Derangements
- Abstract Number: 1506
Multimorbidity in Psoriasis as a Risk Factor for Psoriatic Arthritis: A Population-Based Study
- Abstract Number: 1190
Multimorbidity in Systemic Sclerosis: Burden and Trends in Prevalence from an Incident Population-based Cohort (1980-2018)
- Abstract Number: 1589
Multiple Switching Between the Biosimilar Adalimumab PF-06410293 (Abrilada™) and Reference Adalimumab (Humira®)in Combination with Methotrexate in Patients with Moderately to Severely Active Rheumatoid Arthritis
- Abstract Number: 0335
Multiplexed Mass Cytometry of Cutaneous Lupus Erythematosus and Dermatomyositis Skin: An In-depth B Cell Directed Immunoprofile
- Abstract Number: 0178
Muscle Fibres Play a Critical Role in Therapeutic Response of Myositis to Glucocorticoids Through Polarisation of the Inflammatory Infiltrate by a Paracrine Mechanism
- Abstract Number: 0581
Mutants Improving Stability Enhance the Potency of Treg-Selective IL-2 Mutein for the Treatment of Autoimmune Disorders
- Abstract Number: 1741
Mutated Nod2 Controls T Cell Function and Promotes Uveitis in a Blau Syndrome Mouse Model
- Abstract Number: 0519
Myeloablation Followed by Hematopoietic Stem Cell Transplantation Leads to Long-term Normalization of Systemic Sclerosis Molecular Signatures
- Abstract Number: 0575
Myocardial Infarction and Stroke Risks Among Patients Who Initiated Treatment with Denosumab or Zoledronic Acid for Osteoporosis
- Abstract Number: 1615
Myocardial Infarction in Patients with Systemic Vasculitis and Population Controls: Characteristics and Overall Mortality
- Abstract Number: 1398
Myokine Myostatin Is a Novel Predictor of One-year Radiographic Progression in Patients with Rheumatoid Arthritis
ACR Convergence 2022
November 10-14, 2022. Philadelphia, PA.